Safety profile of rivaroxaban in first-time users treated for venous thromboembolism in four Europea...
Safety profile of rivaroxaban in first-time users treated for venous thromboembolism in four European countries
About this item
Full title
Author / Creator
Publisher
United States: Public Library of Science
Journal title
Language
English
Formats
Publication information
Publisher
United States: Public Library of Science
Subjects
More information
Scope and Contents
Contents
The European rivaroxaban post-authorization safety study evaluated bleeding risk among patients initiated on rivaroxaban or vitamin K antagonists for the treatment and secondary prevention of venous thromboembolism in routine clinical practice.
Cohorts were created using electronic healthcare databases from the UK, the Netherlands, Germany and S...
Alternative Titles
Full title
Safety profile of rivaroxaban in first-time users treated for venous thromboembolism in four European countries
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_21563d3bc5d248d7917f16c59b0f6158
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_21563d3bc5d248d7917f16c59b0f6158
Other Identifiers
ISSN
1932-6203
E-ISSN
1932-6203
DOI
10.1371/journal.pone.0298596
